Exercise function of children with congenital aortic stenosis following aortic valvuloplasty during early infancy

Alaina K Kipps1, Doff B McElhinney, Janet Kane

  • 1Department of Cardiology, Children's Hospital, Boston, Mass 02115, USA. akipps@post.harvard.edu

Congenital Heart Disease
|August 12, 2009
PubMed

Insights

Most patients treated for neonatal aortic stenosis (AS) with balloon aortic valvuloplasty maintain preserved exercise function. However, a significant subset exhibit reduced peak oxygen consumption (VO2), often due to impaired stroke volume.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Exercise Physiology

Background:

  • Balloon aortic valvuloplasty is the standard treatment for neonatal aortic stenosis (AS).
  • Potential long-term effects of AS and its treatment on cardiac structure and function can impact exercise capacity.
  • Understanding exercise function is crucial for managing patients with a history of neonatal AS.

Purpose of the Study:

  • To evaluate the exercise function in patients treated for neonatal AS with balloon aortic valvuloplasty.
  • To identify predictors of exercise dysfunction in this patient population.

Main Methods:

  • Prospective recruitment of patients over 6 years old with a history of neonatal AS.
  • Standardized exercise testing to assess peak oxygen consumption (VO2), O2 pulse, and heart rate.
  • Echocardiographic assessment of aortic stenosis gradient and aortic regurgitation.

Main Results:

  • Thirty patients (median age 13.1 years) with neonatal AS treated via balloon aortic valvuloplasty were studied.
  • Overall peak VO2 was reduced (87% predicted), with severe depression (<70% predicted) in 23% of patients.
  • Peak O2 pulse was generally preserved, but 11 patients had O2 pulse <85% predicted; peak heart rate was also reduced overall.
  • Age at testing inversely correlated with peak VO2; no other factors were associated with VO2.

Conclusions:

  • Exercise function is generally preserved in most individuals treated for neonatal AS in infancy.
  • A subset of these patients demonstrate significantly reduced peak VO2, primarily linked to an inability to augment stroke volume.
  • Long-term monitoring of exercise capacity is important for patients with a history of neonatal aortic stenosis.
Abstract

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...